https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:41947 Wed 22 Mar 2023 14:31:19 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:40374 Wed 13 Mar 2024 08:55:36 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:32516 Wed 13 Jun 2018 11:02:17 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:31072 v standard], 0.96; 90% CI, 0.77 to 1.2). Ten deaths as a result of prostate cancer occurred in the short arm and 12 in the standard arm. No significant differences were detected between arms for grade ≥ 3 late genitourinary and GI toxicity. Conclusion: The hypofractionated RT regimen used in this trial was not inferior to conventional RT and was not associated with increased late toxicity. Hypofractionated RT is more convenient for patients and should be considered for intermediate-risk prostate cancer.]]> Wed 02 Mar 2022 14:26:55 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:37834 P = 0.01). A total of 21% of patients underwent bone scans in the pre-intervention group compared with18% in the post-intervention group (P = 0.84). In intermediate-risk patients, the use of CT decreased from 89% to 34% (P < 0.001), whilst the use of bone scan decreased from 63% to 37% (P = 0.02). In high-risk patients, the appropriate use of imaging was maintained, with CT performed in 87% compared with 85% and bone scan in 87% compared with 65% (P = 0.07). Conclusion: Our results show that a focused, clinician-centred education programme can lead to improved guideline adherence at a regional level. The assessment of trends and application of such a programme at a state-based or national level could be further assessed in the future with the help of registry data. This will be particularly important in future with the advent of advanced imaging, such as prostate-specific membrane antigen positron-emission tomography.]]> Thu 28 Oct 2021 12:35:37 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49877 Thu 08 Jun 2023 15:49:36 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:33046 Thu 03 Feb 2022 12:19:33 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:20621 Sat 24 Mar 2018 07:55:45 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:21357 Sat 24 Mar 2018 07:51:27 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:28752 Sat 24 Mar 2018 07:37:36 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:25708 Sat 24 Mar 2018 07:28:18 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47485 Mon 23 Jan 2023 11:48:41 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52813 Fri 27 Oct 2023 17:01:02 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38069 Fri 12 Nov 2021 12:17:35 AEDT ]]>